http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100473839-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0693 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-09 |
| filingDate | 2002-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2005-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2005-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100473839-B1 |
| titleOfInvention | Human Sarcomatoid Liver Cancer Cell Line |
| abstract | The present invention relates to a human hepatocellular carcinoma cell line, and more particularly to the invasive and metastatic sarcoma hepatocellular carcinoma cell line expressing vimentin, a sarcoma antigen.n n n Human sarcoma hepatocellular carcinoma cell line SH-J1 according to the present invention is a malignant cell line that has been differentiated from hepatocellular carcinoma and has sarcoma antigens and traits, and can be used to develop a diagnostic and therapeutic agent related to metastasis, invasion, etc. Can be. |
| priorityDate | 2002-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 133.